4//SEC Filing
Shawah Robert G. 4
Accession 0001104659-24-043292
CIK 0001736243other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:56 PM ET
Size
5.8 KB
Accession
0001104659-24-043292
Insider Transaction Report
Form 4
Shawah Robert G.
Chief Financial Officer
Transactions
- Award
Stock Option
2024-02-23+145,000→ 145,000 totalExercise: $3.15Exp: 2034-02-22→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 145,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.
Documents
Issuer
Acurx Pharmaceuticals, Inc.
CIK 0001736243
Entity typeother
Related Parties
1- filerCIK 0001601121
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 9:56 PM ET
- Size
- 5.8 KB